Invest now

Sudarshan Pharma Industries share price

High risk
  • 45%Low risk
  • 45%Moderate risk
  • 45%Balanced risk
  • 45%High risk
  • 45%Extreme risk
  • 32.30(-5.00%)
    August 10, 2026 15:27:52 PM IST
    • NSE
    • BSE
  • Vol : 244.00 K (NSE + BSE)
    Last 20 day avg : 319.80 K
Sudarshan Pharma Industries is trading -5.00% lower at Rs 32.30 as compared to its last closing price. Sudarshan Pharma Industries has been trading in the price range of 33.32 & 32.30. Sudarshan Pharma Industries has given 23.41% in this year & -10.27% in the last 5 days. Sudarshan Pharma Industries has TTM P/E ratio 24.95 as compared to the sector P/E of 28.18.Listed peers of Sudarshan Pharma Industries include Sun Pharmaceutical Industries (0.19%), Divi's Laboratories (0.32%), Torrent Pharmaceuticals (-0.74%).The Mutual Fund holding in Sudarshan Pharma Industries was at -% in . The MF holding has - from the last quarter. The FII holding in Sudarshan Pharma Industries was at 19.38% in 30 Jun 2026. The FII holding has decreased from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Loading...
Key Metrics

Updated on 11 Aug 2026, 02:29 AM IST

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.95
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    1.84
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.67
    Indicates Fair Valuation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
32.30
Highest
33.32
52 week range
Lowest
18.50
Highest
42.79
Sudarshan Pharma Industries Peers
Return Comparison
Peers Comparison
Names
Price%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
1,952.750.194,68,519.1038.405.550.830.47
Divi's Laboratories
8,275.000.322,19,675.2573.3211.480.410.03
Torrent Pharmaceuticals
4,915.50-0.741,88,510.3072.7319.220.80141.16
Cipla
1,460.00-0.821,17,945.4227.573.330.921.11
Zydus Lifesciences
1,120.700.491,11,790.2621.194.240.0914.22
Sudarshan Pharma Industries Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-06-18Issue Of Warrants
2026-05-21Others
2026-05-15Others
2026-04-30Audited Results
2026-01-28Quarterly Results
About the company Sudarshan Pharma Industries
  • IndustryBiotechnology & Drugs
  • ISININE00TV01023
  • BSE Code543828
  • NSE Code
Sudarshan Pharma Industries Limited is an India-based company, which is engaged in manufacturing, having a plant for API and doing jobwork manufacturing in Pharmaceutical Items and traders in Chemicals and Solvents in India. The Company is involved in specialty chemicals and intermediates for pharma, agricultural chemicals, coating, paints, adhesive, and various other industries. It is also focused on active pharmaceutical ingredient manufacturing. It is also into specialty chemicals imports and exports, as well as supplying the same to the actual users. The Company provides customized specialty chemicals to its clients in India and abroad regularly. The Company is involved in contract manufacturing, outsourcing and supplying generic pharma formulations and medicines to healthcare institutions, governments, non-governmental organizations (NGO) and hospitals. The Company operates in the states of Maharashtra, Gujarat and Uttarakhand.
  • Management Info
  • Hemal MehtaManaging Director, Executive Chairman of the Borad
  • Sharad KathawateChief Financial Officer
  • Nirav ShahCompliance Officer, Company Secretary
  • Indraraj NeogiHead of Sales and Marketing of Pharma Division
  • Shrinivas PatilExports
  • Santosh ThakurImport Sourcing and Indenting
Sudarshan Pharma Industries Share Price FAQs

Sudarshan Pharma Industries is trading at 32.30 as on Mon Aug 10 2026 09:57:52. This is -5.00% lower as compared to its previous closing price of 34.00.

The market capitalization of Sudarshan Pharma Industries is 777.33 Cr as on Mon Aug 10 2026 09:57:52.

The 52 wk high for Sudarshan Pharma Industries is 42.79 whereas the 52 wk low is 18.50

Sudarshan Pharma Industries can be analyzed on the following key metrics -

  • TTM P/E: 24.95
  • Sector P/E: 28.18
  • Dividend Yield: 0.00%
  • D/E ratio: 1.84

Sudarshan Pharma Industries reported a net profit of 23.30 Cr in 2026.